SCHEMBL1341177

SCHEMBL1341177

CCN(C(=O)C1CCCC1)c1ccc(C(=O)OC)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 2/20 0.49
▸ CNR1 P21554 1/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ NR1H4 Q96RI1 2/20 0.47
▸ RAB9A P51151 1/20 0.45
▸ HSP90AA1 P07900 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ EPHX2 P34913 1/20 0.43
▸ CYP2C19 P33261 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ TSHR P16473 1/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18464205 0.80 NR1H4 (0.58) CNR2CNR1NR1H4SMN1; SMN2
SCHEMBL7141111 0.78 HTT (0.63) CNR2CNR1MEN1KMT2ANR1H4
SCHEMBL5085615 0.73 CNR2 (0.53) CNR2CNR1RAB9A
SCHEMBL6844891 0.72 LOXL2 (0.50) MEN1KMT2AALDH1A1NPC1SMN1; SMN2
SCHEMBL11900371 0.72 SRD5A2 (0.57) MEN1KMT2ARAB9AALDH1A1NPC1
SCHEMBL2938750 0.72 MLYCD (0.60) CNR2CNR1SMN1; SMN2
SCHEMBL65794 0.72 MAPT (0.61) MEN1KMT2AALDH1A1NPC1SMN1; SMN2
SCHEMBL4838149 0.71 NOTUM (0.49) ALDH1A1NPC1SMN1; SMN2HTTKDM4E
SCHEMBL15955652 0.71 ALDH1A1 (0.52) NR1H4HSP90AA1ALDH1A1SMN1; SMN2EPHX2
SCHEMBL22073484 0.70 NR1H4 (0.48) CNR2CNR1MEN1KMT2ANR1H4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8063081-B2 N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase NOVO NORDISK A/S (DK) 2011-11-22 — — US disclosed
US-7897628-B2 {2-[3-(4-Methyl-2-[2-methypropoxy]phenyl)-ureido]-thiazol-4-yl}-acetic acid ethyl ester; glucokinase inhibitor; antidiabetic, hypoglycemic agent; activators of glucokinase NOVO NORDISK A/S (DK) 2011-03-01 — — US disclosed
Send feedback